TABLE 2.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
Comorbidities | ||||||
Asthma | 0.51 | 0.19–1.36 | 0.18 | |||
COPD | 0.95 | 0.39–2.28 | 0.91 | |||
Heart failure | 0.55 | 0.16–1.87 | 0.34 | |||
Non-chronic renal failure | 2.88 | 0.59–14.01 | 0.18 | |||
Pregnancy | 3.28 | 0.68–15.65 | 0.13 | |||
BMI <30% | 0.57 | 0.30–1.08 | 0.08 | |||
APACHE <15 | 2.94 | 1.26–6.87 | <0.05 | |||
SOFA <7 | 15.90 | 3.51–72.06 | <0.01 | |||
CXRqo <2 | 2.89 | 1.35–6.19 | <0.01 | 3.59 | 1.15–11.19 | <0.05 |
Haemodynamic | 12.4 | 5.67–27.09 | <0.01 | 8.18 | 2.07–32.30 | <0.01 |
stability No MODS | 13.45 | 6.47–27.97 | <0.01 | |||
Normal renal function | 8.42 | 1.86–38.09 | <0.01 |
COPD, chronic obstructive pulmonary disease; BMI, body mass index; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment scoring at intensive care unit admission; CXRqo, chest X-ray quadrant opacities; MODS, multiple organ dysfunction syndrome. Haemodynamic stability analysed as absence of vasopressor requirement.